Rotavirus disease in Finnish children: use of numerical scores for clinical severity of diarrhoeal episodes.
about
Vaccines for preventing rotavirus diarrhoea: vaccines in usePerformance of rotavirus vaccines in developed and developing countriesThe paediatric burden of rotavirus disease in EuropeTropical and travel-associated norovirus: current conceptsSystematic review of diarrhea duration and severity in children and adults in low- and middle-income countriesEpidemiology, Seasonality and Factors Associated with Rotavirus Infection among Children with Moderate-to-Severe Diarrhea in Rural Western Kenya, 2008-2012: The Global Enteric Multicenter Study (GEMS)Delayed Dosing of Oral Rotavirus Vaccine Demonstrates Decreased Risk of Rotavirus Gastroenteritis Associated With Serum Zinc: A Randomized Controlled Trial.A Comparison of Diarrheal Severity Scores in the MAL-ED Multisite Community-Based Cohort StudyReduction in diarrhoeal rates through interventions that prevent unnecessary antibiotic exposure early in life in an observational birth cohortEtiology of diarrhea in Bangladeshi infants in the first year of life analyzed using molecular methods.Contribution of enteric infection, altered intestinal barrier function, and maternal malnutrition to infant malnutrition in Bangladesh.Association between Cryptosporidium infection and human leukocyte antigen class I and class II allelesDiarrhoea and smoking: an analysis of decades of observational data from BangladeshEpidemiological and clinical features of rotavirus among children younger than 5 years of age hospitalized with acute gastroenteritis in Northern Italy.Acute childhood diarrhoea in northern Ghana: epidemiological, clinical and microbiological characteristics.Effectiveness of a live oral human rotavirus vaccine after programmatic introduction in Bangladesh: A cluster-randomized trialVaccine against norovirus.Is rotavirus still a major cause for diarrheal illness in hospitalized pediatric patients after rotavirus vaccine introduction in the Saudi national immunization program?Rotavirus vaccines: development and use for the prevention of diarrhoeal disease.Allelic variability of critical virulence genes (eae, bfpA and perA) in typical and atypical enteropathogenic Escherichia coli in Peruvian children.Impact of emergency department probiotic treatment of pediatric gastroenteritis: study protocol for the PROGUT (Probiotic Regimen for Outpatient Gastroenteritis Utility of Treatment) randomized controlled trial.Association between mixed rotavirus vaccination types of infants and rotavirus acute gastroenteritis.An instrument for the assessment of diarrhoeal severity based on a longitudinal community-based studyBurden of rotavirus gastroenteritis in the Middle Eastern and North African pediatric population.Hospital-based surveillance to estimate the burden of rotavirus gastroenteritis in children below five years of age in Romania.Effectiveness of rotavirus vaccination against childhood diarrhoea in El Salvador: case-control study.Astrovirus MLB1 is not associated with diarrhea in a cohort of Indian children.Genotypic and phenotypic characterization of enterotoxigenic Escherichia coli strains isolated from Peruvian children.Burden of community-acquired and nosocomial rotavirus gastroenteritis in the pediatric population of Western Europe: a scoping review.Protective effect of natural rotavirus infection in an Indian birth cohort.Symptomatic and asymptomatic Cryptosporidium infections in children in a semi-urban slum community in southern India.Human rotavirus vaccine (RIX4414) efficacy in the first two years of life: a randomized, placebo-controlled trial in China.The impact of childhood acute rotavirus gastroenteritis on the parents' quality of life: prospective observational study in European primary care medical practices.Association of serum anti-rotavirus immunoglobulin A antibody seropositivity and protection against severe rotavirus gastroenteritis: analysis of clinical trials of human rotavirus vaccine.Virological, serological, and clinical features of an outbreak of acute gastroenteritis due to recombinant genogroup II norovirus in an infant home.Understanding reduced rotavirus vaccine efficacy in low socio-economic settings.Immune response and intestinal permeability in children with acute gastroenteritis treated with Lactobacillus rhamnosus GG: a randomized, double-blind, placebo-controlled trialA cost effectiveness and capacity analysis for the introduction of universal rotavirus vaccination in Kenya: comparison between Rotarix and RotaTeq vaccines.The impact of Rotavirus mass vaccination on hospitalization rates, nosocomial Rotavirus gastroenteritis and secondary blood stream infectionsHospital bed occupancy for rotavirus and all cause acute gastroenteritis in two Finnish hospitals before and after the implementation of the national rotavirus vaccination program with RotaTeq®
P2860
Q24197495-6E803D1B-53E1-4072-8241-DE3701006FA4Q24600612-7FE92380-8571-49CF-887D-9AFCBBACA580Q24617563-D9A4768D-4EC4-4B0A-8429-493468AA4108Q26799737-664BD723-220B-45FD-A0B5-5372126DE461Q26862724-A11CC0BF-B6D1-49B7-B4CF-99D180DE49D0Q30276185-61EA8709-7CC8-443E-96CC-65FEB3211B8BQ30276748-6125471B-1761-44DB-AE99-05AC3B213B15Q30355334-BA576D84-10F1-4452-9C18-74637E3B67BBQ30356480-F708F1C5-2AFE-4693-A377-E5F20E5CA63FQ30409328-DA5F1409-10EE-45F9-93CB-B5EB86DB6970Q30422841-0D2D343D-F0D3-47E7-B229-844C6E84380DQ30425869-0C645036-8A08-48EB-914E-A60651BC3E74Q30979803-B1A26616-DD91-4206-A836-67BBA376F1D0Q30986181-E471195F-C9FD-4413-9A5A-855C2B4725F3Q33297811-C903CC84-DEE7-4B2D-96B6-D4B414FA7265Q33574342-6E6D1BB4-68BA-4F94-9228-6CE277278DC6Q33578075-53AC5739-057A-43A1-9858-446448BCC804Q33597262-9D03173E-9581-4CEC-A5B2-7A8F25DC7EE3Q33603410-95E60AEA-4959-4E95-A7FD-9C9427DD0481Q33663829-4BAA0062-1B58-4AE9-B7FD-742A358954B0Q33682584-DF912FA2-3E97-4BC0-8E7A-6D4C08DF9615Q33727179-5ACD983D-F8A6-441D-B628-5FF4A6F215D2Q33744811-B5DAFE06-56BB-402D-8E0C-C96D7CB19F1CQ33788473-1E60CC18-EBB9-49A5-BD5A-019872BAB556Q33794728-56F463E3-CFB7-4ACC-A9CE-AAEBC6A343B6Q33915516-ED539950-4C19-45C1-B0CE-EF7B350D8804Q34103238-7ED4504B-2920-4253-9A3A-062CFF1054FDQ34120382-7C0BDEFB-ED79-4500-8F36-F27CBF4DF0E7Q34201777-EC533FCC-A1F3-4798-A992-0FC879282B16Q34203915-81E116D3-E860-4ECA-8025-6E770FAC79C9Q34240125-1B15BAA9-19EA-46E0-89B3-02294C66E5BAQ34271468-76829D9A-D4F8-4759-A838-8540E334F583Q34287906-EC12B32C-480C-40E3-9662-FDFAECF1BCE4Q34290838-EBC20C30-EA28-4DEE-B533-DC62C1E2732BQ34315446-33FF5D0A-FEE5-4C25-9AB5-E9CD648B17C7Q34374045-F269B051-5FA7-4334-B449-387195137748Q34402709-CDD269DF-BBD5-4992-A5F8-F2BC219454DFQ34463522-5EED8248-979F-498D-BDB5-68BC12913A90Q34604662-5326A982-698B-4B09-9E50-FDC57D3C6B23Q34706627-749E8201-13C0-47D1-A842-E3C4539C7601
P2860
Rotavirus disease in Finnish children: use of numerical scores for clinical severity of diarrhoeal episodes.
description
1990 nî lūn-bûn
@nan
1990 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Rotavirus disease in Finnish c ...... verity of diarrhoeal episodes.
@ast
Rotavirus disease in Finnish c ...... verity of diarrhoeal episodes.
@en
Rotavirus disease in Finnish c ...... verity of diarrhoeal episodes.
@nl
type
label
Rotavirus disease in Finnish c ...... verity of diarrhoeal episodes.
@ast
Rotavirus disease in Finnish c ...... verity of diarrhoeal episodes.
@en
Rotavirus disease in Finnish c ...... verity of diarrhoeal episodes.
@nl
prefLabel
Rotavirus disease in Finnish c ...... verity of diarrhoeal episodes.
@ast
Rotavirus disease in Finnish c ...... verity of diarrhoeal episodes.
@en
Rotavirus disease in Finnish c ...... verity of diarrhoeal episodes.
@nl
P2860
P1476
Rotavirus disease in Finnish c ...... verity of diarrhoeal episodes.
@en
P2093
P2860
P304
P356
10.3109/00365549009027046
P577
1990-01-01T00:00:00Z